Analysts’ Opinions Are Mixed on These Real Estate Stocks: Realty Income (O), Healthpeak Properties (DOC) and NETSTREIT (NTST)
Companies in the Real Estate sector have received a lot of coverage today as analysts weigh in on Realty Income (O), Healthpeak Properties (DOC) and NETSTREIT (NTST).
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Realty Income (O)
Scotiabank analyst Greg McGinniss maintained a Buy rating on Realty Income today and set a price target of $69.00. The company’s shares closed last Monday at $64.92.
According to TipRanks.com, McGinniss is a 3-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Realty Income with a $67.39 average price target, a 3.7% upside from current levels. In a report issued on April 8, TipRanks – DeepSeek also upgraded the stock to Buy with a $69.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Healthpeak Properties (DOC)
In a report released today, Nicholas Yulico from Scotiabank maintained a Hold rating on Healthpeak Properties, with a price target of $19.00. The company’s shares closed last Monday at $17.10.
According to TipRanks.com, Yulico is a 3-star analyst with an average return of
Healthpeak Properties has an analyst consensus of Moderate Buy, with a price target consensus of $18.86, which is a 9.2% upside from current levels. In a report released yesterday, UBS also initiated coverage with a Hold rating on the stock with a $17.00 price target.
NETSTREIT (NTST)
In a report released yesterday, Michael Gorman from BTIG maintained a Buy rating on NETSTREIT, with a price target of $22.00. The company’s shares closed last Monday at $20.89.
According to TipRanks.com, Gorman is a 4-star analyst with an average return of
Currently, the analyst consensus on NETSTREIT is a Strong Buy with an average price target of $22.36, which is a 6.9% upside from current levels. In a report released yesterday, BMO Capital also initiated coverage with a Buy rating on the stock with a $24.00 price target.
Read More on O:
